Tofacitinib
Tofacitinib is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis.
| Catalog Number | T6321 |
| Alternative Name(s) | Tasocitinib , CP-690550 |
| Research Area | Cell Cycle/Checkpoint|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Stem Cells|||Apoptosis|||Cytoskeletal Signaling|||Angiogenesis|||Chromatin/Epigenetic |
| Molecular Formula | C16H20N6O |
| CAS# | 477600-75-2 |
| Purity | 99.74% |
| SMILES | N(C)(C1=C2C(NC=C2)=NC=N1)[C@H]3CN(C(CC#N)=O)CC[C@H]3C |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Tofacitinib |
| Additional Information | https://www.targetmol.com/datasheet/T6321 |